Michael E. Woods, MD


Fifer GL, Raynor MC, Selph P, Woods ME, Wallen EM, Viprakasit DP, Nielsen M, Smith AM, Pruthi RS. Robotic Ureteral Reconstruction Distal to the Ureteropelvic Junction: A Large Single Institution Clinical Series with Short Term Follow-Up. J Endourol. 2014 Aug 5. [Epub ahead of print]

Johnson DC, Vukina J, Smith AB, Meyer AM, Wheeler SB, Kuo TM, Tan HJ, Woods ME, Raynor MC, Wallen EM, Pruthi RS, Nielsen ME. Preoperatively Misclassified, Surgically Removed Benign Renal Masses: A Systematic Review of Surgical Series and United States Population-Level Burden Estimate. J Urol. 2014 Jul 26. [Epub ahead of print]

McMillan DT, Viera AJ, Matthews J, Raynor MC, Woods ME, Pruthi RS, Wallen EM, Nielsen ME, Smith AB. Resident involvement and experience do not affect perioperative complications following robotic prostatectomy. World J Urol. 2014 Jul 2. [Epub ahead of print]

Selph JP, Whited WM, Smith AB, Matthews J, Pruthi RS, Wallen EM, Nielsen ME, Woods ME. Metabolic syndrome as a predictor for postoperative complications after urologic surgery. Urology. 2014 May;83(5):1051-9. doi: 10.1016/j.urology.2014.01.014. Epub 2014 Mar 20.

Smith AB, Deal AM, Yu H, Boyd B, Matthews J, Wallen EM, Pruthi RS, Woods ME, Muss H, Nielsen ME. Sarcopenia as a Predictor of Complications and Survival Following Radical Cystectomy. J Urol. 2014 Jan 11. [Epub ahead of print]

Smith AB, Deal AM, Woods ME, Wallen EM, Pruthi RS, Chen RC, Milowsky MI, Nielsen ME. Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base. BJU Int. 2013 Dec 11. [Epub ahead of print]

Johnson DC, Nielsen ME, Matthews J, Woods ME, Wallen EM, Pruthi RS, Milowsky MI, Smith AB. Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity. BJU Int. 2014 Aug;114(2):221-8. Epub 2014 Mar 14.

Langston JP, Kirby EW, Nielsen ME, Smith AB, Woods ME, Wallen EM, Pruthi RS. Economic impact of training and career decisions on urological surgery. J Urol. 2014 Mar;191(3):755-60. Epub 2013 Oct 2.

Chism DD, Woods ME, Milowsky MI.  Neoadjuvant paradigm for accelerated drug development:  an ideal model in bladder cancer. Oncologist. 2013;18(8):933-40. Epub 2013 Jul 24.

Johnson DC, Woods ME, Pruthi RS.  Perioperative Chemotherapy:  When to use it, what to us, and why.  Urol Clin North Am.  2013 May;40(2):183-95. Epub 2013 Feb 28.

Smith AB, Woods ME, Raynor MC, Nielsen ME, Wallen EM, Pruthi RS.  Prevention and management of complications following robot-assisted radical cystectomy:  lessons learned after >250 consecutive cases.  World J Urol  Dec 2012.

Polcari AJ, Allen JC, Nunez-Nateras R, Mmeje CO, Andrews PE, Milner JE, Castle EP, Woods ME.  Multicenter Experience with robot assisted radical prostatectomy in renal transplant recipients.  Urology  Dec 2012; 80(6):1267

Johnson D, Castle E, Pruthi RS, Woods ME.  Robotic intracorporeal urinary diversion:  ileal conduit.  J Endourol 2012; 26(12):1566

Polcari AJ, Farooq AV, Woods M, Ripsch MS, Picken MM, Turk T, White FA.  Effect of the phosphodiesterase-5 inhibitor Zaprinast on ischemia-reperfusion injury in rats.  J Endourol  Sep 2012; epub

Mmeje CO, Nunez-Nateras R, Nielsen ME, Pruthi RS, Smith A, Wallen EM, Humphreys MR, Woods ME, Castle EP.  Oncologic outcomes for lymph node-positive urothelial carcinoma patients treated with robot assisted radical cystectomy:  With mean follow-up of 3.5 years.  Urol Oncol, 2012 Apr 23.  Epub ahead of print.

Smith AB, Raynor M, Amling CL, Busby JE, Castle E, Davis R, Nielsen M, Thomas R, Wallen EM, Woods ME, Pruthi RS.  Multi-institutional analysis of robotic radical cystectomy for bladder cancer:  perioperative outcomes and complications in 227 patients.  J Laparoendosc Adv Surg Tech A, 2012 Jan-Feb; 22(1):17-21.  Epub 2011 Dec 5.

Woods ME, Wiklund P, Castle EP.  Robot-assisted radical cystectomy:  recent advances and review of the literature.  Curr Opin Urol, 2010 Mar; 20(2):125-9.  Review.

Martin AD, Nunez RN, Pacelli A, Woods ME, Davis R, Thomas R, Andrews PE, Castle EP.  Robot-assisted radical cystectomy:  intermediate survival results at a mean follow-up of 25 months.  BJU Int, 2010 June; 105(12):1706-9.  Epub 2009 Nov 9.

Polcari AJ, Hugen CM, Sivarajan G, Woods ME, Paner GP, Flanigan RC, Quek ML.  Comparison of open and robot-assisted pelvic lymphadenectomy for prostate cancer.  J Endourol, 2009 Aug; 23(8)1313-7.

Woods ME, Ouwenga M, Quek ML.  The role of pelvic lmphadenectomy in the management of prostate and bladder cancer.  Scientific World Journal, 2007 Mar 2; 7:789-99.  Review.

Search for additional publications on PubMed using woods me as search criteria.